Republic Bank Az (RBAZ) 4.6000 $RBAZ RepublicBankAz

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Republic Bank Az (RBAZ) 4.6000 $RBAZ

RepublicBankAz Announces Unaudited Financial Results For the Quarter Ending June 30, 2016
GlobeNewswire - Tue Aug 02, 5:06PM CDT
RepublicBankAz,N.A. (OTCBB:RBAZ) ("RBAz" announced a net income of $56,000, or $.03 per share, for the quarter ended June 30, 2016 as compared to a net income of $95,000 or $.07 per share for the same period in 2015.

RepublicBankAz Announces Unaudited Financial Results for the Quarter Ending March 31, 2016
GlobeNewswire - Fri May 06, 7:00PM CDT
First quarter brings favorable results

RepublicBankAz Announces Unaudited Financial Results for the Quarter Ending September 30, 2015
GlobeNewswire - Thu Nov 05, 1:00PM CST
RepublicBankAz, N.A. (OTCBB:RBAZ) ("RBAz" announced a net income of $140,000, or $.08 per share, for the quarter ended September 30, 2015 as compared to a net income of $219,000 or $.17 per share for the same period in 2014.

Amy Lou Blunt Joins RepublicBankAz as Executive Vice President and Chief Credit Officer
GlobeNewswire - Thu Oct 22, 5:30PM CDT
RepublicBankAz (OTCQB:RBAZ) announced that Amy Lou Blunt has been named executive vice president and chief credit officer. This announcement was made by Ralph Tapscott, chief executive officer and president of RepublicBankAz.

RepublicBankAz Announces Unaudited Financial Results for the Year Ending December 31, 2014
GlobeNewswire - Fri Feb 06, 5:17PM CST
RepublicBankAz, N.A. (OTCBB:RBAZ) ("RBAz" announced a net income of $516,000, or $.36 per diluted share, for the year ended December 31, 2014 as compared to a net loss of $392,000 or -$.28 per diluted share, for the same period in 2013. For the quarter ended December 31, 2014 RBAz reported a net loss of $22,000, or -$.01 per diluted share as compared to a net loss of $891,000, or -$.65 per diluted share for the same period in 2013.

RepublicBankAz, N.A. Releases 3rd Quarter 2014 Earnings
GlobeNewswire - Mon Nov 03, 3:00PM CST
RepublicBankAz, N.A. (OTCBB:RBAZ) ("RBAz" announced net income of $219,000, or $.16 per diluted share, for the quarter ended September 30, 2014 as compared to net income $397,000 or $.29 per diluted share, for the same period in 2013. For the nine months ended September 30, 2014 RBAz reported net income of $538,000, or $.39 per diluted share as compared to a net income of $499,000, or $.36 per diluted share for the same period of 2013. Ralph Tapscott, President and CEO, states "We are pleased with the consistent run rate in core earnings we have seen throughout the year. Our focus on safety and soundness dominates our growth objectives, and we feel we are making significant strides."

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oscar Health Options Activity and Market Insights for Investors

Updated Category News Views 265

Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...

Continue Reading
Better Choice Company Finalizes Sale of Halo Asia Business

Updated Category News Views 160

Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....

Continue Reading
Fastenal Prepares for Earnings Report: What Investors Should Know

Updated Category News Views 154

Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....

Continue Reading
Compass Therapeutics Takes Major Steps in Biliary Cancer Trials

Updated Category News Views 203

Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...

Continue Reading
Understanding the Recent ECB Fine on LHV Group and Its Implications

Updated Category News Views 218

Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...

Continue Reading